查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933299

全球冠狀動脈支架市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察、未來預測（2026-2034）

Coronary Stent Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 160 Pages | 商品交期: 請詢問到貨日

價格

冠狀動脈支架市場成長驅動因素

2025年全球冠狀動脈支架市場規模達到70.2億美元，並預計從2026年的73.8億美元成長至2034年的122.6億美元，2026年至2034年的年複合成長率（CAGR）為6.54%。北美地區在2025年佔據市場主導地位，市場佔有率達33.55%，這得益於其完善的醫療保健基礎設施、冠狀動脈疾病（CAD）的高發病率以及監管部門批准推動的頻繁產品上市。

冠狀動脈支架是一種小型管狀裝置，插入冠狀動脈以保持其暢通。它們主要用於經皮冠狀動脈介入治療（PCI），以治療動脈粥狀硬化等疾病。全球心血管疾病發生率的上升、支架植入技術的進步以及 PCI 手術精準度的提高，推動其在已開發市場和新興市場的應用。

市場驅動因素

冠狀動脈疾病盛行率上升

全球冠狀動脈疾病盛行率的上升是推動市場發展的關鍵因素。導致這現象的因素包括久坐的生活方式、壓力和不健康的飲食習慣。根據美國疾病管制與預防中心（CDC）的資料，到2023年，約有 5%的20 歲及以上成年人將患有冠狀動脈疾病（CAD），這意味著龐大的患者群體將推動對支架的需求。此外，全球人口老化，老年人更容易患上冠狀動脈疾病，這也進一步加速了市場成長。

技術進步

支架設計方面的創新，例如藥物洗脫支架（DES）和生物可吸收支架，提高了安全性和臨床療效。Medtronic公司的Onyx Frontier DES（2022年獲得 FDA 批准）等器械採用了改進的輸送系統，有助於進行複雜的經皮冠狀動脈介入治療（PCI）手術。微創介入、再狹窄率降低以及支架柔軟度提高，促使全球心臟科醫師日益採用這些器材。

市場限制

副作用與監管障礙

動脈損傷、過敏反應和再狹窄等併發症阻礙了支架的廣泛應用。嚴格的監管審批也限制了某些地區的產品供應。產品召回，例如2022年 Atrium Medical 公司召回的iCast 塗層支架，可能會對患者的信心和市場擴張產生負面影響。

市場機會

在新興地區，由於人們對心血管疾病的認識不斷提高、專科醫院的擴建以及導管室的發展，預計將出現顯著的成長機會。印度的公共心臟健康運動（2023年）以及澳洲和印度2024年的醫院擴建計畫表明，醫療服務的可及性和公眾意識都在提高，這為支架的普及創造了機會。

市場趨勢

冠狀動脈支架技術的持續創新（例如，減少支柱厚度、提高柔韌性以及引進生物分解聚合物）推動市場成長。例如，Medinol公司的EluNIR-PERL藥物洗脫支架於2023年獲得FDA批准，有助於改善患者預後並提高手術效率。

細分市場分析

依支架類型

  • 藥物洗脫支架（DES）將主導市場，到2026年將佔據 76.51%的市場佔有率，這主要得益於監管部門的批准、臨床需求以及再狹窄率的下降。雅培的XIENCE Sierra DES 於2024年在印度上市，正是此一趨勢的典型代表。
  • 裸金屬支架由於適用於出血風險高的患者，因此保持適度成長。
  • 生物可吸收支架的市場擴張，這主要歸因於人口老化和慢性心血管疾病的增加。
  • 覆膜支架市場成長，這主要得益於 BIOTRONIK 於2019年推出的用於緊急穿孔治療的PK Papyrus 等產品。

依材料分類

  • 金屬支架（不鏽鋼、鈷鉻合金和鉑鉻合金）將在2024年佔據市場主導地位，並有望憑藉其高效性和耐用性保持領先地位。
  • 用於生物可吸收裝置的聚合物支架也因其臨床優勢而有望成長。

依置入方式分類

  • 自膨式支架將在2026年佔據69.11%的市場佔有率，展現出較高的臨床療效。
  • 球囊擴張式支架將因技術進步和經皮冠狀動脈介入治療（PCI）的廣泛應用而保持穩定成長。

依應用領域

  • 到2026年，慢性冠狀動脈症候群（CCS）將佔據89.21%的市場佔有率，這反映了冠狀動脈疾病（CAD）的高發生率。
  • 急性冠狀動脈症候群（ACS）領域成長，這主要得益於急性病例經皮冠狀動脈介入治療（PCI）手術量的增加。

依最終使用者

  • 醫院和門診手術中心（ASC）是市場的主要驅動力，這得益於其高手術量、先進的基礎設施以及新建心臟護理機構（例如，美國弗吉尼亞州，2024年）。
  • 專科診所的成長較為溫和，這主要得益於心臟科醫師網路的擴展和病患意識的提高。
  • 其他機構（例如導管室）也在穩定擴張。

依地區劃分的預測

  • 北美：到2025年，市場規模達到23.5億美元，主要得益於先進的基礎設施和冠狀動脈疾病（CAD）的高發病率。
  • 歐洲：預期成長溫和。預計到2026年，英國和德國的市場規模將分別達到5.1億美元和6.4億美元。
  • 亞太地區：預計成長迅速。預計到2026年，日本市場規模將達到2.5億美元，中國將達到3.9億美元，印度將達到3.3億美元，主要得益於醫院的擴建和新型支架的上市（例如，Terumo的Ultimaster Nagomi支架計劃於2023年在印度上市）。
  • 拉丁美洲、中東和非洲：由於冠狀動脈疾病病例和血管成形術的增加，預計市場將保持穩定成長。

依支架種類：藥物洗脫支架

  • 覆膜支架
  • 裸金屬支架
  • 生物可吸收支架
  • 其他（雙效治療支架）

依材質：金屬

  • 聚合物

依置入方式*：自膨式

  • 球囊擴張式

依用途：急性冠狀動脈疾病/冠狀動脈症候群（ACS）

  • 慢性冠狀動脈症候群（CCS）

依最終使用者：醫院和門診手術中心（ASC）

  • 專科診所
  • 其他

依地區：北美（支架類型、材料類型、植入方法、應用、最終用戶、國家）

  • 美國
  • 加拿大
  • 歐洲（依支架類型、材料類型、植入方法、應用、最終用戶和國家劃分））
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 歐洲其他地區
  • 亞太地區（依支架類型、材料類型、植入方法、應用、最終用戶和國家劃分）
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 東南亞
    • 亞太其他地區
  • 拉丁美洲（依支架類型、材料類型、植入方法、應用、最終用戶及國家）
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲（依支架類型、材料類型、植入方式、應用、最終用戶及國家劃分）
    • GCC國家
    • 南非
    • 中東和非洲其他地區

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • 主要國家和地區冠狀動脈疾病（CAD）盛行率（2023/2025）
  • 冠狀動脈支架技術進展
  • 主要廠商新產品發布
  • 主要產業趨勢：併購、業務合作等
  • 新冠疫情對市場的影響

第5章 全球冠狀動脈支架市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依支架類型劃分
    • 藥物洗脫支架
    • 覆膜支架
    • 裸金屬支架
    • 生物可吸收支架
    • 其他
  • 市場分析、洞察與預測：依材料類型劃分
    • 金屬
    • 聚合物
  • 市場分析、洞察與預測：以植入方式劃分
    • 自膨式支架
    • 球囊擴張式支架
  • 市場分析、洞察與預測：依應用劃分
    • 急性冠狀動脈症候群（ACS）
    • 慢性冠狀動脈症候群（CCS）
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院和門診手術中心（ASC）
    • 專科診所
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北部美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美冠狀動脈支架市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第7章 歐洲冠狀動脈支架市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 其他歐洲國家

第8章 亞太地區冠狀動脈支架市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 東南亞
    • 亞太其他地區

第9章 拉丁美洲冠狀動脈支架市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第10章 中東與非洲冠狀動脈支架市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • GCC國家
    • 南亞非洲
    • 其他中東和非洲地區

第11章 競爭分析

  • 全球市場佔有率分析（2025年）
  • 公司簡介
  • Medtronic
  • Boston Scientific Corporation
  • BIOTRONIK SE &Co. KG
  • Terumo Corporation
  • Abbott
  • Relisys Medical Devices Limited.
  • B. Braun SE
  • MicroPort Scientific Corporation
  • Stentys S.A.
  • Meril Life Sciences Pvt. Ltd.
Product Code: FBI100065

Growth Factors of coronary stents Market

The global coronary stents market was valued at USD 7.02 billion in 2025 and is projected to grow from USD 7.38 billion in 2026 to USD 12.26 billion by 2034, registering a CAGR of 6.54% during 2026-2034. North America dominated the market in 2025 with a 33.55% share, supported by robust healthcare infrastructure, high prevalence of coronary artery diseases (CAD), and frequent product launches backed by regulatory approvals.

Coronary stents are small, tube-shaped devices inserted into coronary arteries to keep them open, primarily used in Percutaneous Coronary Interventions (PCI) to treat conditions like atherosclerosis. The rising global incidence of cardiovascular diseases, technological advancements in stenting procedures, and improved accuracy in PCI operations are driving adoption in both developed and emerging markets.

MARKET DRIVERS

Rising Prevalence of Coronary Heart Disease

The growing prevalence of coronary heart disorders globally is a key market driver. Sedentary lifestyles, stress, and unhealthy eating habits are contributing factors. According to the U.S. CDC, about 5% of adults aged 20+ had CAD in 2023, highlighting a significant patient pool driving demand for stents. Additionally, the aging global population, more prone to CAD, further propels market growth.

Technological Advancements

Innovations in stent design, such as drug-eluting stents (DES) and bioresorbable stents, have enhanced safety and clinical outcomes. Devices like Medtronic's Onyx Frontier DES (FDA approved in 2022) feature improved delivery systems, facilitating complex PCI procedures. Minimally invasive interventions, reduced restenosis rates, and enhanced stent flexibility are increasing adoption among cardiologists worldwide.

MARKET RESTRAINTS

Side Effects and Regulatory Barriers

Complications like arterial damage, allergic reactions, or restenosis can hinder adoption. Strict regulatory approvals also limit product entry in certain regions. Product recalls, such as Atrium Medical's iCast-covered stents in 2022, negatively impact patient trust and market expansion.

MARKET OPPORTUNITIES

Emerging regions present significant growth potential due to rising awareness of cardiovascular diseases, expansion of specialty hospitals, and establishment of catheterization labs. Initiatives like India's public heart health campaigns (2023) and hospital expansions in Australia and India in 2024 demonstrate increasing accessibility and awareness, creating opportunities for stent adoption.

MARKET TRENDS

Continuous innovations in coronary stents, including reducing strut thickness, improving flexibility, and introducing biodegradable polymers, are shaping market growth. Examples include Medinol's EluNIR-PERL DES, FDA approved in 2023, enhancing patient outcomes and procedural efficiency.

SEGMENTATION ANALYSIS

By Stent Type

  • Drug-eluting stents (DES) dominate with 76.51% market share in 2026, driven by regulatory approvals, clinical demand, and reduced restenosis rates. Abbott's XIENCE Sierra DES launched in India in 2024 exemplifies this trend.
  • Bare metal stents maintain moderate growth due to suitability in high-bleeding-risk patients.
  • Bioresorbable stents are expanding due to increasing elderly populations and chronic cardiovascular conditions.
  • Covered stents grow via product launches like BIOTRONIK's PK Papyrus in 2019 for emergency perforation treatments.

By Material

  • Metal-based stents (stainless steel, cobalt-chromium, platinum-chromium) dominate in 2024 and are projected to continue leading due to efficiency and durability.
  • Polymer-based stents (used in bioresorbable devices) are also witnessing growth due to clinical benefits.

By Deployment

  • Self-expandable stents accounted for 69.11% share in 2026, offering high clinical efficiency.
  • Balloon-expandable stents maintain stable growth, benefiting from technological enhancements and PCI procedures.

By Application

  • Chronic Coronary Syndrome (CCS) dominated in 2026 with 89.21% share, reflecting high CAD prevalence.
  • Acute Coronary Syndrome (ACS) segment grows due to rising PCI procedures for acute events.

By End-User

  • Hospitals & Ambulatory Surgical Centers (ASCs) dominate due to high procedure volumes, advanced infrastructure, and opening of new cardiac care facilities (e.g., Virginia, U.S., 2024).
  • Specialty clinics show moderate growth, fueled by increasing cardiologist networks and patient awareness.
  • Others (catheterization labs) are steadily expanding.

REGIONAL OUTLOOK

  • North America: USD 2.35 billion in 2025, dominating due to advanced infrastructure and high CAD prevalence.
  • Europe: Moderate growth; UK USD 0.51 billion and Germany USD 0.64 billion in 2026.
  • Asia Pacific: Rapid growth; Japan USD 0.25 billion, China USD 0.39 billion, India USD 0.33 billion in 2026, driven by hospital expansions and new stent launches (Terumo Ultimaster Nagomi in India, 2023).
  • Latin America & Middle East & Africa: Steady growth due to rising CAD cases and angioplasty procedures.

COMPETITIVE LANDSCAPE

Key players include Abbott, Medtronic, Boston Scientific, BIOTRONIK, Terumo, MicroPort, B. Braun SE, Stentys, Meril Life Sciences, and Relisys Medical. Strategic acquisitions, regulatory approvals, and clinical trials are the primary growth strategies. Notable developments: Abbott acquiring CSI in 2023 and MicroPort receiving NMPA approval for Firesorb in 2024.

CONCLUSION

The global coronary stents market is projected to grow steadily from USD 7.02 billion in 2025 to USD 12.26 billion by 2034, driven by rising CAD prevalence, technological advancements in stent design, and expansion of healthcare infrastructure worldwide. While procedural risks, regulatory barriers, and product recalls pose challenges, innovations such as drug-eluting, bioresorbable, and self-expandable stents, coupled with emerging regional opportunities, ensure a robust growth trajectory. North America maintains dominance, while Asia Pacific exhibits the highest growth potential, creating significant opportunities for both established and emerging market players.

Segmentation Stent Type, Material Type, Deployment, Application, End-user, and Region

By Stent Type * Drug Eluting Stent

  • Covered Stent
  • Bare Metal Stent
  • Bioresorbable Stent
  • Others (Dual Therapy Stents)

By Material Type * Metal

  • Polymer

By Deployment * Self-expandable

  • Balloon-expandable

By Application * Acute Coronary Syndrome (ACS)

  • Chronic Coronary Syndrome (CCS)

By End-user * Hospitals & ASCs

  • Specialty Clinics
  • Others

By Region * North America (By Stent Type, Material Type, Deployment, Application, End-user, and Country)

    • U.S.
    • Canada
  • Europe (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Coronary Artery Disease (CAD), by Key countries/sub-region, 2023/2025
  • 4.2. Technological Advancements in Coronary Stents
  • 4.3. New Product Launches, By Key Players
  • 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.5. Impact of COVID-19 on the Market

5. Global Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Stent Type
    • 5.1.1. Drug Eluting Stent
    • 5.1.2. Covered Stent
    • 5.1.3. Bare Metal Stent
    • 5.1.4. Bioresorbable Stent
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Material Type
    • 5.2.1. Metal
    • 5.2.2. Polymer
  • 5.3. Market Analysis, Insights and Forecast - By Deployment
    • 5.3.1. Self-expandable
    • 5.3.2. Balloon-expandable
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Acute Coronary Syndrome (ACS)
    • 5.4.2. Chronic Coronary Syndrome (CCS)
  • 5.5. Market Analysis, Insights and Forecast - By End-user
    • 5.5.1. Hospitals & ASCs
    • 5.5.2. Specialty Clinics
    • 5.5.3. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Stent Type
    • 6.1.1. Drug Eluting Stent
    • 6.1.2. Covered Stent
    • 6.1.3. Bare Metal Stent
    • 6.1.4. Bioresorbable Stent
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Material Type
    • 6.2.1. Metal
    • 6.2.2. Polymer
  • 6.3. Market Analysis, Insights and Forecast - By Deployment
    • 6.3.1. Self-expandable
    • 6.3.2. Balloon-expandable
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Acute Coronary Syndrome (ACS)
    • 6.4.2. Chronic Coronary Syndrome (CCS)
  • 6.5. Market Analysis, Insights and Forecast - By End-user
    • 6.5.1. Hospitals & ASCs
    • 6.5.2. Specialty Clinics
    • 6.5.3. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Stent Type
    • 7.1.1. Drug Eluting Stent
    • 7.1.2. Covered Stent
    • 7.1.3. Bare Metal Stent
    • 7.1.4. Bioresorbable Stent
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Material Type
    • 7.2.1. Metal
    • 7.2.2. Polymer
  • 7.3. Market Analysis, Insights and Forecast - By Deployment
    • 7.3.1. Self-expandable
    • 7.3.2. Balloon-expandable
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Acute Coronary Syndrome (ACS)
    • 7.4.2. Chronic Coronary Syndrome (CCS)
  • 7.5. Market Analysis, Insights and Forecast - By End-user
    • 7.5.1. Hospitals & ASCs
    • 7.5.2. Specialty Clinics
    • 7.5.3. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.6.1. Germany
    • 7.6.2. U.K.
    • 7.6.3. France
    • 7.6.4. Italy
    • 7.6.5. Spain
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Stent Type
    • 8.1.1. Drug Eluting Stent
    • 8.1.2. Covered Stent
    • 8.1.3. Bare Metal Stent
    • 8.1.4. Bioresorbable Stent
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Material Type
    • 8.2.1. Metal
    • 8.2.2. Polymer
  • 8.3. Market Analysis, Insights and Forecast - By Deployment
    • 8.3.1. Self-expandable
    • 8.3.2. Balloon-expandable
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Acute Coronary Syndrome (ACS)
    • 8.4.2. Chronic Coronary Syndrome (CCS)
  • 8.5. Market Analysis, Insights and Forecast - By End-user
    • 8.5.1. Hospitals & ASCs
    • 8.5.2. Specialty Clinics
    • 8.5.3. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. Australia
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Stent Type
    • 9.1.1. Drug Eluting Stent
    • 9.1.2. Covered Stent
    • 9.1.3. Bare Metal Stent
    • 9.1.4. Bioresorbable Stent
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Material Type
    • 9.2.1. Metal
    • 9.2.2. Polymer
  • 9.3. Market Analysis, Insights and Forecast - By Deployment
    • 9.3.1. Self-expandable
    • 9.3.2. Balloon-expandable
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Acute Coronary Syndrome (ACS)
    • 9.4.2. Chronic Coronary Syndrome (CCS)
  • 9.5. Market Analysis, Insights and Forecast - By End-user
    • 9.5.1. Hospitals & ASCs
    • 9.5.2. Specialty Clinics
    • 9.5.3. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Stent Type
    • 10.1.1. Drug Eluting Stent
    • 10.1.2. Covered Stent
    • 10.1.3. Bare Metal Stent
    • 10.1.4. Bioresorbable Stent
    • 10.1.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Material Type
    • 10.2.1. Metal
    • 10.2.2. Polymer
  • 10.3. Market Analysis, Insights and Forecast - By Deployment
    • 10.3.1. Self-expandable
    • 10.3.2. Balloon-expandable
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Acute Coronary Syndrome (ACS)
    • 10.4.2. Chronic Coronary Syndrome (CCS)
  • 10.5. Market Analysis, Insights and Forecast - By End-user
    • 10.5.1. Hospitals & ASCs
    • 10.5.2. Specialty Clinics
    • 10.5.3. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, Financials (based on availability), Recent Developments, Strategies, SWOT, Etc.)
    • 11.2.1. Medtronic
    • 11.2.2. Boston Scientific Corporation
    • 11.2.3. BIOTRONIK SE & Co. KG
    • 11.2.4. Terumo Corporation
    • 11.2.5. Abbott
    • 11.2.6. Relisys Medical Devices Limited.
    • 11.2.7. B. Braun SE
    • 11.2.8. MicroPort Scientific Corporation
    • 11.2.9. Stentys S.A.
    • 11.2.10. Meril Life Sciences Pvt. Ltd.

List of Tables

  • Table 1: Global Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 2: Global Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 3: Global Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 4: Global Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5: Global Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 6: Global Coronary Stents Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 8: North America Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 9: North America Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 10: North America Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: North America Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 12: North America Coronary Stents Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 14: Europe Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 15: Europe Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 16: Europe Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 17: Europe Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 18: Europe Coronary Stents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 20: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 21: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 22: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 24: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 26: Latin America Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 27: Latin America Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 28: Latin America Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 29: Latin America Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 30: Latin America Coronary Stents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 32: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 33: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 34: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 35: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 36: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Coronary Stents Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Coronary Stents Market Value Share (%), by Stent Type, 2025 & 2034
  • Figure 3: Global Coronary Stents Market Value Share (%), by Material Type, 2025 & 2034
  • Figure 4: Global Coronary Stents Market Value Share (%), by Deployment, 2025 & 2034
  • Figure 5: Global Coronary Stents Market Value Share (%), by Application, 2025 & 2034
  • Figure 6: Global Coronary Stents Market Value Share (%), by End-user, 2025 & 2034
  • Figure 7: Global Coronary Stents Market Value (USD billion), by Region, 2025 & 2034
  • Figure 8: North America Coronary Stents Market Value (USD billion), by Stent Type, 2025 & 2034
  • Figure 9: North America Coronary Stents Market Value Share (%), by Stent Type, 2025
  • Figure 10: North America Coronary Stents Market Value (USD billion), by Material Type, 2025 & 2034
  • Figure 11: North America Coronary Stents Market Value Share (%), by Material Type, 2025
  • Figure 12: North America Coronary Stents Market Value (USD billion), by Deployment, 2025 & 2034
  • Figure 13: North America Coronary Stents Market Value Share (%), by Deployment, 2025
  • Figure 14: North America Coronary Stents Market Value (USD billion), by Application, 2025 & 2034
  • Figure 15: North America Coronary Stents Market Value Share (%), by Application, 2025
  • Figure 16: North America Coronary Stents Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 17: North America Coronary Stents Market Value Share (%), by End-user, 2025
  • Figure 18: North America Coronary Stents Market Value (USD billion), by Country, 2025 & 2034
  • Figure 19: North America Coronary Stents Market Value Share (%), by Country, 2025
  • Figure 20: Europe Coronary Stents Market Value (USD billion), by Stent Type, 2025 & 2034
  • Figure 21: Europe Coronary Stents Market Value Share (%), by Stent Type, 2025
  • Figure 22: Europe Coronary Stents Market Value (USD billion), by Material Type, 2025 & 2034
  • Figure 23: Europe Coronary Stents Market Value Share (%), by Material Type, 2025
  • Figure 24: Europe Coronary Stents Market Value (USD billion), by Deployment, 2025 & 2034
  • Figure 25: Europe Coronary Stents Market Value Share (%), by Deployment, 2025
  • Figure 26: Europe Coronary Stents Market Value (USD billion), by Application, 2025 & 2034
  • Figure 27: Europe Coronary Stents Market Value Share (%), by Application, 2025
  • Figure 28: Europe Coronary Stents Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 29: Europe Coronary Stents Market Value Share (%), by End-user, 2025
  • Figure 30: Europe Coronary Stents Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 31: Europe Coronary Stents Market Value Share (%), by Country/Sub-region, 2025
  • Figure 32: Asia Pacific Coronary Stents Market Value (USD billion), by Stent Type, 2025 & 2034
  • Figure 33: Asia Pacific Coronary Stents Market Value Share (%), by Stent Type, 2025
  • Figure 34: Asia Pacific Coronary Stents Market Value (USD billion), by Material Type, 2025 & 2034
  • Figure 35: Asia Pacific Coronary Stents Market Value Share (%), by Material Type, 2025
  • Figure 36: Asia Pacific Coronary Stents Market Value (USD billion), by Deployment, 2025 & 2034
  • Figure 37: Asia Pacific Coronary Stents Market Value Share (%), by Deployment, 2025
  • Figure 38: Asia Pacific Coronary Stents Market Value (USD billion), by Application, 2025 & 2034
  • Figure 39: Asia Pacific Coronary Stents Market Value Share (%), by Application, 2025
  • Figure 40: Asia Pacific Coronary Stents Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 41: Asia Pacific Coronary Stents Market Value Share (%), by End-user, 2025
  • Figure 42: Asia Pacific Coronary Stents Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Coronary Stents Market Value Share (%), by Country/Sub-region, 2025
  • Figure 44: Latin America Coronary Stents Market Value (USD billion), by Stent Type, 2025 & 2034
  • Figure 45: Latin America Coronary Stents Market Value Share (%), by Stent Type, 2025
  • Figure 46: Latin America Coronary Stents Market Value (USD billion), by Material Type, 2025 & 2034
  • Figure 47: Latin America Coronary Stents Market Value Share (%), by Material Type, 2025
  • Figure 48: Latin America Coronary Stents Market Value (USD billion), by Deployment, 2025 & 2034
  • Figure 49: Latin America Coronary Stents Market Value Share (%), by Deployment, 2025
  • Figure 50: Latin America Coronary Stents Market Value (USD billion), by Application, 2025 & 2034
  • Figure 51: Latin America Coronary Stents Market Value Share (%), by Application, 2025
  • Figure 52: Latin America Coronary Stents Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 53: Latin America Coronary Stents Market Value Share (%), by End-user, 2025
  • Figure 54: Latin America Coronary Stents Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 55: Latin America Coronary Stents Market Value Share (%), by Country/Sub-region, 2025
  • Figure 56: Middle East & Africa Coronary Stents Market Value (USD billion), by Stent Type, 2025 & 2034
  • Figure 57: Middle East & Africa Coronary Stents Market Value Share (%), by Stent Type, 2025
  • Figure 58: Middle East & Africa Coronary Stents Market Value (USD billion), by Material Type, 2025 & 2034
  • Figure 59: Middle East & Africa Coronary Stents Market Value Share (%), by Material Type, 2025
  • Figure 60: Middle East & Africa Coronary Stents Market Value (USD billion), by Deployment, 2025 & 2034
  • Figure 61: Middle East & Africa Coronary Stents Market Value Share (%), by Deployment, 2025
  • Figure 62: Middle East & Africa Coronary Stents Market Value (USD billion), by Application, 2025 & 2034
  • Figure 63: Middle East & Africa Coronary Stents Market Value Share (%), by Application, 2025
  • Figure 64: Middle East & Africa Coronary Stents Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 65: Middle East & Africa Coronary Stents Market Value Share (%), by End-user, 2025
  • Figure 66: Middle East & Africa Coronary Stents Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa Coronary Stents Market Value Share (%), by Country/Sub-region, 2025
  • Figure 68: Global Coronary Stents Market Share (%), By Company, 2025